Literature DB >> 11794213

More on pamidronate in Langerhans'-cell histiocytosis.

R E Brown.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11794213

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Distinctive growth pattern in a patient with a delayed diagnosis of Langerhans' cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Gregory A Kaltsas; Georgios Delimpasis; Ludwig Wilkens; George Kanakis; Polyzois Makras
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

2.  Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series.

Authors:  Shanthi Sivendran; Harold Harvey; Allan Lipton; Joseph Drabick
Journal:  Int J Hematol       Date:  2011-04-26       Impact factor: 2.490

3.  Langerhans Cell Histiocytosis of the Temporal Bone with Otic Capsule Involvement.

Authors:  J M Blumberg; A Malhotra; X Wu; R K Virk; J F Kveton; E M Michaelides
Journal:  Clin Neuroradiol       Date:  2015-09-04       Impact factor: 3.649

4.  Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.

Authors:  Sanda Alexandrescu; Nina Tatevian; Bogdan A Czerniak; Michael H Covinsky; Nadja K Burns; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29

Review 5.  Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.

Authors:  Caroline Hutter; Milen Minkov
Journal:  Immunotargets Ther       Date:  2016-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.